ADLM 2024 marks the 7th year of the Disruptive Technology Award Competition (DTAC). Review the information below and past competitions to see if your technology is a good fit. Contact [email protected] with any additional questions.
Learn How to Submit an Application
Dates are subject to change.
DTAC welcomes applications from companies that are in the early to late stages of developing new, disruptive diagnostic tools and/or technologies and have developed a clear vision of how they will position their product in the marketplace. Technologies entering the competition should be relatively unknown to the laboratory medicine community and be working to improve patient care through diagnostic performance or access to high quality testing. Applicants must be ready and willing to present data to support the viability of their technology.
Prior applicants are encouraged to reapply with the same technology, provided that the technology was not selected as a finalist and includes significant progress since the last application. The committee strongly recommends that prior applicants skip at least one annual competition to allow time to gather additional data. There is dedicated space in the application to highlight the changes since your last application.
Applicants for the competition help DTAC serve the laboratory medicine community’s need to learn about new technologies to improve patient care. In exchange, applicants have the opportunity to receive:
A team of experts in commercializing diagnostic tools and technologies will evaluate applicants on the three core components that make a technology disruptive: Innovation, Impact, and Commercialization. More details and specific factors used for each component can be found on the Application Evaluation page. Applications are evaluated in three phases:
Here are the top recommendations from the faculty to make your application stand out.
Be the first to get all the latest news.